ResMed CFO Aaron Bloomer acquires 9,072 shares

Q: When do ResMed CFO Aaron Bloomer’s restricted stock units vest?

The performance-based restricted stock units vest one-third each year on the anniversary of the June 1, 2026 grant. They were earned on August 14, 2026, when the compensation and leadership development committee certified that the applicable performance metrics were met.

The chief financial officer’s performance-based restricted stock units were earned after the committee certified that the applicable performance metrics were met.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

ResMed Inc. Chief Financial Officer Aaron Bloomer reported acquiring 9,072 shares of common stock on August 14, 2026, representing performance-based restricted stock units granted June 1, 2026. The units were earned when the compensation and leadership development committee certified that the applicable performance metrics were met. Bloomer reported direct holdings of 9,072 shares following the transaction.

Insider Trade Summary

Grant/Award: 9,072 shares

Grant/Award 1 txn

Insider Bloomer Aaron

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	ResMed Common Stock ^F1	9,072	$0.00	$0.00

Holdings After Transaction: ResMed Common Stock — 9,072 shares (Direct)

Footnotes (1)

F1. Represents performance-based restricted stock units granted on June 1, 2026. The RSUs were earned on August 14, 2026, when the compensation and leadership development committee certified that the applicable performance metrics were met. RSUs vest 1/3 each year on the anniversary of the grant.

Key Figures

Shares acquired: 9,072 shares Direct shares held following transaction: 9,072 shares Grant date: June 1, 2026 +2 more

5 metrics

Shares acquired 9,072 shares August 14, 2026

Direct shares held following transaction 9,072 shares Reported after the August 14, 2026 transaction

Grant date June 1, 2026 Performance-based restricted stock units

Earning date August 14, 2026 After certification of applicable performance metrics

Annual vesting portion 1/3 Each year on the grant anniversary

Key Terms

performance-based restricted stock units, performance metrics, vest

3 terms

performance-based restricted stock units financial

"performance-based restricted stock units granted on June 1, 2026"

Performance-based restricted stock units are a type of employee equity award that converts into company shares only if predefined financial or operational targets are met over a set period. Think of it like a bonus check that becomes stock only when specific goals are hit; it ties pay to results, aligning managers’ incentives with shareholders. Investors care because these awards affect future share count, executive incentives, and signal how management’s success will be measured and rewarded.

performance metrics financial

"the applicable performance metrics were met"

Performance metrics are concrete numbers or ratios that show how well a business, product, or investment is doing—like speed, fuel use and mileage on a car’s dashboard. They measure things investors care about, such as sales growth, profitability, cash flow, customer retention or efficiency, so readers can compare progress, spot strengths or problems, and make informed decisions about buying, holding or selling shares.

vest financial

"RSUs vest 1/3 each year on the anniversary of the grant"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did ResMed’s CFO acquire?

Aaron Bloomer, ResMed Inc.’s chief financial officer, acquired 9,072 shares of common stock on August 14, 2026. The shares represented performance-based restricted stock units earned after the compensation and leadership development committee certified that the applicable performance metrics were met.

When do ResMed CFO Aaron Bloomer’s restricted stock units vest?

The performance-based restricted stock units vest one-third each year on the anniversary of the June 1, 2026 grant. They were earned on August 14, 2026, when the compensation and leadership development committee certified that the applicable performance metrics were met.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/01/2026 - 04:08 PM Accepted by SEC EDGAR 10/01/2026 - 04:08 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bloomer Aaron

(Last)

(First)

(Middle)

RESMED INC.

9001 SPECTRUM CENTER BLVD.

(Street)

SAN DIEGO

CALIFORNIA

92123

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RESMED INC [ RMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
ResMed Common Stock	08/14/2026		A⁽¹⁾		9,072	A	$0	9,072	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents performance-based restricted stock units granted on June 1, 2026. The RSUs were earned on August 14, 2026, when the compensation and leadership development committee certified that the applicable performance metrics were met. RSUs vest 1/3 each year on the anniversary of the grant.

	/s/ Lisa Beyer, attorney-in-fact for Mr. Bloomer	10/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR